PYNNACLE phase II assessing rezatapopt in patients with advanced solid tumors, including lung cancer, harboring a TP53 Y220C mutation Meeting Abstract


Authors: De Miguel, M. J.; Dumbrava, E. E.; Body, A.; Eberst, L.; Frenel, J. S.; Italiano, A.; Johnson, M. L.; Kaczmar, J.; Kummar, S.; Lorusso, P. M.; Millward, M.; Ray-Coquard, I. L.; Scambia, G.; Spira, A.; Tan, D. S.; Thompson, J. A.; Qin, Y.; Fellous, M.; Schram, A.
Abstract Title: PYNNACLE phase II assessing rezatapopt in patients with advanced solid tumors, including lung cancer, harboring a TP53 Y220C mutation
Meeting Title: European Lung Cancer Congress (ELCC) 2025
Journal Title: Journal of Thoracic Oncology
Volume: 20
Issue: 3 Suppl. 1
Meeting Dates: 2025 Mar 26-29
Meeting Location: Paris, France
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2025-03-01
Start Page: S231
End Page: S232
Language: English
ACCESSION: WOS:001464133600097
PROVIDER: wos
DOI: 10.1016/s1556-0864(25)00592-1
Notes: Meeting Abstract: 400TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alison Michele Schram
    122 Schram